Tech Company Financing Transactions

NanoCellect Biomedical Funding Round

Illumina Ventures, 5 Prime Ventures and Agilent Technologies invested in a $10 million Series B capital raise for NanoCellect Biomedical. This venture round was recorded on 12/1/2017.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

9525 Towne Centre Dr. 150
San Diego, CA 92121
USA

Phone

(877) 745-7678

Website

www.nanocellect.com

Email Address

[email protected]

Overview

NanoCellect's mission is to facilitate biomedical breakthroughs by making cell analysis and sorting technology more affordable and easier to use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, and basic research.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Operating Officer

William Alaynick

        

Chief Technical Officer

Sunghwan Cho

        

President

José Morachis

        

VP - Finance

Fiona Chou

        

Browse more venture capital transactions:

Prev: 12/1/2017: resTORbio venture capital transaction
Next: 12/1/2017: Eleven James venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary